Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression-Reference-Cited by-同舟云学术

Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression

Published:2019-06-13 Issue:2 Volume:370 Page:327-336
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Ayyar Vivaswath S.,DuBois Debra C.,Nakamura Toshimichi,Almon Richard R.,Jusko William J.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference50 articles.

1. Mechanistic Multi—Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics

2. Modeling corticosteroid pharmacokinetics and pharmacodynamics, part III: estrous cycle and estrogen receptor-dependent antagonism of GILZ enhancement by corticosteroids;Ayyar;J Pharmacol Exp Ther,2019

3. Modeling corticosteroid pharmacokinetics and pharmacodynamics, part I: determination and prediction of dexamethasone and methylprednisolone tissue binding in the rat;Ayyar;J Pharmacol Exp Ther,2019

4. Pathways of drug metabolism;Brodie;J Pharm Pharmacol,1956

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach;Journal of Pharmaceutical Sciences;2024-01

2. Fifty Years of Unraveling the Clinical Pharmacology of Corticosteroids;Journal of Pharmaceutical Sciences;2024-01

3. Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives;Cells;2023-08-16

4. Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance;Drug Metabolism and Disposition;2023-07-17

5. Emerging nanoparticle platforms to improve the administration of glucocorticoids;Journal of Controlled Release;2023-06